Agilent Announces Cell Analysis Workflow Automation for Immu

Agilent Announces Cell Analysis Workflow Automation for Immuno-Oncology, Virology, and Vaccine Development Markets

24.02.2023 - Agilent Technologies Inc. (NYSE: A) today announced their xCELLigence RTCA HT (real-time cell analysis high-throughput) platform now integrates with the BioTek BioSpa 8 Automated Incubator. Developed in response to market needs, this combination ...

Related Keywords

Todd Christian , Robert Carnahan , Agilent Technologies Inc , Agilent Technologies , Vanderbilt University Medical Center , Facebook , Vanderbilt Vaccine Center , Agilent Cell Analysis Division , Cell Analysis , Vanderbilt University Medical , Agilent Technologies Stock ,

© 2025 Vimarsana